Livewire Ergogenics
LiveWire Ergogenics, Inc., engages in the development and marketing of handcrafted cannabis-based and hemp-derived products for medical and recreational use in the United States. It is also involved in developing and licensing cannabinoid-based specialty products and services under the SOL VIDA Wellness and Estrella Weedery brand names. LiveWire Ergogenics, Inc. is based in Anaheim, California.
Livewire Ergogenics (LVVV) - Total Assets
Latest total assets as of September 2025: $3.56 Million USD
Based on the latest financial reports, Livewire Ergogenics (LVVV) holds total assets worth $3.56 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Livewire Ergogenics - Total Assets Trend (2007–2024)
This chart illustrates how Livewire Ergogenics’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Livewire Ergogenics - Asset Composition Analysis
Current Asset Composition (December 2024)
Livewire Ergogenics's total assets of $3.56 Million consist of 94.3% current assets and 5.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $7.50 Million | 94.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how Livewire Ergogenics's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Livewire Ergogenics's current assets represent 94.3% of total assets in 2024, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2024, down from 68.1% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 94.2% of total assets.
Livewire Ergogenics Competitors by Total Assets
Key competitors of Livewire Ergogenics based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Livewire Ergogenics - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Livewire Ergogenics generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Livewire Ergogenics generates $ 0.99 in net profit.
Livewire Ergogenics - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.13 | 1.60 | 0.38 |
| Quick Ratio | 0.13 | 1.60 | 0.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.64 Million | $ 2.81 Million | $ -1.94 Million |
Livewire Ergogenics - Advanced Valuation Insights
This section examines the relationship between Livewire Ergogenics's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | $7.96 Million |
| Market Capitalization | $3.62 USD |
Valuation Analysis
Below Book Valuation: The market values Livewire Ergogenics's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Livewire Ergogenics's assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Livewire Ergogenics (2007–2024)
The table below shows the annual total assets of Livewire Ergogenics from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $7.96 Million | +2.93% |
| 2023-12-31 | $7.74 Million | +23.34% |
| 2022-12-31 | $6.27 Million | +38.73% |
| 2021-12-31 | $4.52 Million | +55.43% |
| 2020-12-31 | $2.91 Million | -12.47% |
| 2019-12-31 | $3.32 Million | +89.67% |
| 2018-12-31 | $1.75 Million | +1451.89% |
| 2017-12-31 | $112.89K | -22.74% |
| 2016-12-31 | $146.12K | -10.13% |
| 2015-12-31 | $162.58K | -47.50% |
| 2014-12-31 | $309.64K | +391.79% |
| 2013-12-31 | $62.96K | -8.68% |
| 2012-12-31 | $68.95K | -35.20% |
| 2011-12-31 | $106.40K | +212692.00% |
| 2008-12-31 | $50.00 | -99.95% |
| 2007-12-31 | $94.05K | -- |